Novartis India Ltd (NOVARTIND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 333626, "name": "Novartis India", "stock_name": "Novartis India", "full_name": "Novartis India Ltd", "name_url": "stocks-analysis/novartis-india", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "839.00", "chg": 14.65, "chgp": "1.78%", "dir": 1, "prev_price": "824.35", "mcapval": "2,037.00 Cr", "mcap": "Small Cap", "scripcode": 500672, "symbol": "NOVARTIND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE234A01025", "curr_date": "Feb 09", "curr_time": "", "bse_nse_vol": "20.92 k", "exc_status": "Active", "traded_date": "Feb 09, 2026", "traded_date_str": "2026 02 09", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novartis-india-333626-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Novartis India Gains 8.57%: Technical Momentum Shift Drives Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-gains-857-technical-momentum-shift-drives-weekly-rally-3827063", "imagepath": "", "date": "2026-02-08 09:00:13", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Stock opens at ₹764.75, up 0.72% despite Sensex decline</p>\n <p><strong>3 Feb:</strong> Gains accelerate to 1.65% as Sensex rebounds strongly</p>\n <p><strong>4 Feb:</strong> Sharp 6.43% jump following technical upgrade and strong volume</p>\n <p><strong>5 Feb:</strong> Slight dip of 0.35% amid mixed technical signals</p>\n <p><strong>6 Feb:</strong> Week closes at ₹824.35, marginally down 0.02% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.759.30</div><..." }, { "title": "Novartis India Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3821827", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NovartisIndiaLt_mojoScore_3821827.png", "date": "2026-02-05 08:12:31", "description": "Novartis India Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in technical indicators despite ongoing financial challenges. The upgrade, effective from 04 Feb 2026, is driven primarily by improvements in technical trends, while valuation and financial performance remain under pressure. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change." }, { "title": "Novartis India Ltd Sees Technical Momentum Shift Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3821568", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NovartisIndiaLt_technicaldot_3821568.png", "date": "2026-02-05 08:01:14", "description": "Novartis India Ltd has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend, accompanied by a 6.43% surge in its share price on 5 Feb 2026. Despite this positive price movement, key technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes that investors should carefully consider." }, { "title": "Why is Novartis India Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-novartis-india-ltd-fallingrising-3821398", "imagepath": "", "date": "2026-02-05 00:54:26", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Outperformance</strong></p>\n<p>Novartis India Ltd has demonstrated robust gains in the recent trading sessions, with the stock appreciating by 5.68% over the past week and 6.16% in the last month. Year-to-date, the stock has risen by 6.21%, contrasting favourably against the Sensex, which declined by 1.65% over the same period. This outperformance is further underscored by the stock’s consecutive two-day gain, delivering an 8.19% return in that span. On 04-Feb, the stock reached an intraday high of ₹841.65, marking an 8.26% increase from previous levels and outperforming its sector by 6.62% on the day.</p>\n<p>Technical indicators also support this upward trend, with the current price sitting above the 5-day, 20-day, and 50-day moving averages, signalling ..." }, { "title": "Novartis India Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-strong-sell-3816261", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NovartisIndiaLt_mojoScore_3816261.png", "date": "2026-02-02 10:10:26", "description": "Novartis India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 02 February 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Novartis India Declines 3.42%: 3 Key Factors Driving the Weekly Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-declines-342-3-key-factors-driving-the-weekly-downturn-3813839", "imagepath": "", "date": "2026-02-01 09:01:31", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 27:</strong> Stock opens strong at Rs.800.75 (+1.86%) amid initial optimism</p>\n <p><strong>Jan 28:</strong> Q3 FY26 results reveal 36.8% profit slump, stock drops 2.22%</p>\n <p><strong>Jan 29:</strong> Negative financial trend and bearish technical momentum deepen losses</p>\n <p><strong>Jan 30:</strong> Week closes at Rs.759.30, down 0.78% on final trading day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.786.15</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">W..." }, { "title": "Novartis India Ltd Faces Bearish Momentum Amid Technical Indicator Shifts", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-faces-bearish-momentum-amid-technical-indicator-shifts-3808658", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NovartisIndiaLt_technicaldot_3808658.png", "date": "2026-01-29 08:00:47", "description": "Novartis India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s technical landscape reveals a complex interplay of bullish and bearish signals across weekly and monthly timeframes, underscoring the challenges facing investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Novartis India Ltd Reports Declining Quarterly Performance Amid Negative Financial Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-reports-declining-quarterly-performance-amid-negative-financial-trend-3808575", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NovartisIndiaLt_fintrenddot_3808575.png", "date": "2026-01-29 08:00:09", "description": "Novartis India Ltd has reported a marked deterioration in its financial performance for the quarter ended December 2025, with key metrics such as net sales, profit after tax, and operating margins showing significant contraction. This downturn contrasts sharply with the company’s historical trend of stable growth, signalling challenges ahead for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Are Novartis India Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-novartis-india-ltd-latest-results-good-or-bad-3808224", "imagepath": "", "date": "2026-01-28 19:15:52", "description": "The latest financial results for Novartis India Ltd reveal significant operational challenges. In the third quarter of FY26, the company reported a net profit of ₹16.09 crore, reflecting a substantial decline of 36.8% compared to the previous quarter. Revenue also contracted by 7.63% to ₹85.90 crore, indicating difficulties in maintaining sales momentum. The operating margin fell to 26.03%, marking the lowest level in recent quarters, which suggests increased cost pressures and pricing challenges in the pharmaceutical sector.\n\nThe sequential analysis shows volatility in both revenue and profitability. While the second quarter of FY26 exhibited a modest revenue growth of 3.18%, the sharp downturn in the third quarter raises concerns about the sustainability of these gains. The net profit trajectory has been particularly troubling, with declines in two of the last three quarters, highlighting execution challe..." } ], "total": 207, "sid": "333626", "stock_news_url": "https://www.marketsmojo.com/news/novartis-india-333626" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "29-Jan-2026", "details": "Intimation of newspaper advertisement by Novartis India Limited (the Company) regarding the publication of Unaudited Financial Results of the Company for the quarter ended December 31 2025.", "source": "BSE" }, { "caption": "Rumour verification - Regulation 30(11)", "datetime": "29-Jan-2026", "details": "Clarification regarding incorrect financial figures of Novartis India Limited for Q3 2025-26 reported in Free Press Journal article dated January 28 2026. The article has now been taken down.", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited (The Company) Held On Wednesday January 28 2026.", "datetime": "28-Jan-2026", "details": "Outcome of the Meeting of the Board of Directors of Novartis India Limited (the Company) held on Wednesday January 28 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Novartis India Ltd has declared <strong>500%</strong> dividend, ex-date: 23 Jul 25", "dt": "2025-07-23", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Jan 27: Stock opens strong at Rs.800.75 (+1.86%) amid initial optimism

Jan 28: Q3 FY26 results reveal 36.8% profit slump, stock drops 2.22%

Jan 29: Negative financial trend and bearish technical momentum deepen losses

Jan 30: Week closes at Rs.759.30, down 0.78% on final trading day

Week Open

Rs.786.15

W...

Read full news article

Novartis India Ltd Faces Bearish Momentum Amid Technical Indicator Shifts

2026-01-29 08:00:47

Novartis India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s technical landscape reveals a complex interplay of bullish and bearish signals across weekly and monthly timeframes, underscoring the challenges facing investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Novartis India Ltd Reports Declining Quarterly Performance Amid Negative Financial Trend

2026-01-29 08:00:09

Novartis India Ltd has reported a marked deterioration in its financial performance for the quarter ended December 2025, with key metrics such as net sales, profit after tax, and operating margins showing significant contraction. This downturn contrasts sharply with the company’s historical trend of stable growth, signalling challenges ahead for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Are Novartis India Ltd latest results good or bad?

2026-01-28 19:15:52

The latest financial results for Novartis India Ltd reveal significant operational challenges. In the third quarter of FY26, the company reported a net profit of ₹16.09 crore, reflecting a substantial decline of 36.8% compared to the previous quarter. Revenue also contracted by 7.63% to ₹85.90 crore, indicating difficulties in maintaining sales momentum. The operating margin fell to 26.03%, marking the lowest level in recent quarters, which suggests increased cost pressures and pricing challenges in the pharmaceutical sector. The sequential analysis shows volatility in both revenue and profitability. While the second quarter of FY26 exhibited a modest revenue growth of 3.18%, the sharp downturn in the third quarter raises concerns about the sustainability of these gains. The net profit trajectory has been particularly troubling, with declines in two of the last three quarters, highlighting execution challe...

Read full news article